Endometriosis Trial, Recruiting (NCT05245695)

Endometriosis Trial, Recruiting NCT05245695 Sponsor: Aspira Women's Health Condition: Endometriosis

Printed from Voxsanity (voxsanity.com.au) — NCT05245695 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometriosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing and able to sign a written consent form agreeing to take part.
You are a female between 14 and 50 years old at the time of signing the consent form.
You are already scheduled to have open or keyhole surgery because your symptoms suggest you may have endometriosis.

Who may not be able to join:

You have not yet had your first menstrual period.
You are currently pregnant.
You currently have an active cancer diagnosis.
You have previously tested positive for HIV or hepatitis A, B, or C.
You currently have an active infection in your pelvis or any other infection that would make surgery unsafe.
You have taken part in another clinical trial involving an experimental drug, device, or procedure within 3 months before joining, or have one planned within 3 months of joining.
You have a general health or behavioural condition that the trial doctor believes would make it unsuitable for you to participate (confirm with trial site).
You are under 14 or over 50 years old.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Todd Pappas, PhD, Aspira Women's Health

Phone: 844-277-4721

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05245695

Sponsor: Aspira Women's Health

Phase: Not Applicable

Status: Recruiting

Condition: Endometriosis

Trial contact: 844-277-4721

More information: https://clinicaltrials.gov/study/NCT05245695

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing and able to sign a written consent form agreeing to take part.
You are a female between 14 and 50 years old at the time of signing the consent form.
You are already scheduled to have open or keyhole surgery because your symptoms suggest you may have endometriosis.

Who may not be able to join:

You have not yet had your first menstrual period.
You are currently pregnant.
You currently have an active cancer diagnosis.
You have previously tested positive for HIV or hepatitis A, B, or C.
You currently have an active infection in your pelvis or any other infection that would make surgery unsafe.
You have taken part in another clinical trial involving an experimental drug, device, or procedure within 3 months before joining, or have one planned within 3 months of joining.
You have a general health or behavioural condition that the trial doctor believes would make it unsuitable for you to participate (confirm with trial site).
You are under 14 or over 50 years old.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Aspira Women's Health

Registry

ClinicalTrials.gov

Start date

12 July 2022

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sensitivity and Specificity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov